Steven M. Burghart, DPh, MBA, BCPP
CPNP Immediate Past President
On June 17, 2014, CPNP submitted comments to USP on the first draft of General Chapter 800 Hazardous Drugs – Handling in Healthcare Settings. Our comments included opposition to the use of NIOSH 2012 Hazardous Drugs List as the mandatory minimum list of hazardous medications. The original draft chapter specified that all facilities must treat all medications on the NIOSH list as hazardous. The NIOSH list contains many psychotropics that are commonly used is psychiatry without special handling precautions including, carbamazepine, clonazepam, oxcarbazepine, paroxetine, risperidone, valproate and ziprasidone. Implementation of the draft standards as initially written would have placed an impossible burden on facilities that handle these medications.
USP released a revised draft General Chapter 800 in December 2014. CPNP is pleased to report that the revised draft chapter incorporated improvements that address many of our previous concerns.
Significant revisions to the chapter included:
CPNP submitted a second letter of comment to USP on May 4, 2015. CPNP requested that USP consider exclusion of non-antineoplastic agents (psychotropics) that are on the NIOSH list from USP Chapter 800. Additionally, CPNP requested that the requirement for maintaining medical surveillance records (quantities of hazardous drugs handled, etc.) be eliminated for non-antineoplastic agents. USP has been very responsive to input from CPNP leadership. We look forward to working with them on this important issue.
To assist membership with meeting the requirements of USP Chapter 800, CPNP has launched a new task force under the leadership of Ann Richards. This task force began its work in April 2016. The task force is charged with reviewing USP Chapter 800 and: